1. Home
  2. LGND vs WMK Comparison

LGND vs WMK Comparison

Compare LGND & WMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • WMK
  • Stock Information
  • Founded
  • LGND 1987
  • WMK 1912
  • Country
  • LGND United States
  • WMK United States
  • Employees
  • LGND N/A
  • WMK N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • WMK Food Chains
  • Sector
  • LGND Health Care
  • WMK Consumer Staples
  • Exchange
  • LGND Nasdaq
  • WMK Nasdaq
  • Market Cap
  • LGND 2.0B
  • WMK 1.9B
  • IPO Year
  • LGND 1992
  • WMK N/A
  • Fundamental
  • Price
  • LGND $122.40
  • WMK $74.59
  • Analyst Decision
  • LGND Strong Buy
  • WMK
  • Analyst Count
  • LGND 8
  • WMK 0
  • Target Price
  • LGND $144.71
  • WMK N/A
  • AVG Volume (30 Days)
  • LGND 139.7K
  • WMK 123.1K
  • Earning Date
  • LGND 08-05-2025
  • WMK 08-05-2025
  • Dividend Yield
  • LGND N/A
  • WMK 1.84%
  • EPS Growth
  • LGND N/A
  • WMK 6.00
  • EPS
  • LGND N/A
  • WMK 3.99
  • Revenue
  • LGND $181,488,000.00
  • WMK $4,810,301,000.00
  • Revenue This Year
  • LGND $18.41
  • WMK N/A
  • Revenue Next Year
  • LGND $18.87
  • WMK N/A
  • P/E Ratio
  • LGND N/A
  • WMK $18.57
  • Revenue Growth
  • LGND 53.40
  • WMK 1.23
  • 52 Week Low
  • LGND $81.74
  • WMK $61.58
  • 52 Week High
  • LGND $129.90
  • WMK $90.23
  • Technical
  • Relative Strength Index (RSI)
  • LGND 70.36
  • WMK 48.54
  • Support Level
  • LGND $111.72
  • WMK $73.46
  • Resistance Level
  • LGND $115.53
  • WMK $76.18
  • Average True Range (ATR)
  • LGND 3.46
  • WMK 1.71
  • MACD
  • LGND 0.18
  • WMK 0.29
  • Stochastic Oscillator
  • LGND 85.52
  • WMK 65.53

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

Share on Social Networks: